维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Senderowicz AM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Inhibitors of cyclin-dependent kinase modulators for cancer therapy显示文摘	Senderowicz AM		0，，：	1
2	Preclinical and clinical development of cyclin-dependent kinase modulators 显示文摘	Senderowicz AM Sausville EA	2000	J Natl Cancer Inst2000，92，5：	1
3	Small molecule modulators of cyclin-dependent ki- nases for cancer therapy显示文摘	Senderowicz AM	2000	Oncogene2000，19，56：	1
4	Novel small molecule eyelin-dependent kinases modulators in human clinical trials 显示文摘	Senderowicz AM	2003	Cancer Biol Ther2003，2，41：	1
5	Inhibitors of cyclin-dependent kinase modulators for cancer therapy显示文摘	Senderowicz AM	2005	Prog Drug Res2005，63，：	1
6	Targeting cell cycle and apoptosis for the treatment of human malignancies显示文摘	Senderowicz AM	2004	Current Opinion in Cell Biology2004，16，6：	1
7	Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs 显示文摘	Frijhoff AF Conti C J Senderowicz AM	2004	Mol Carcinog2004，39，4：	1
8	Development of cyclin-dependent kinase modulator as novel therapeutic approaches for hematological malignancies显示文摘	Senderowicz AM	2001	Leukemia2001，15，1：	1
9	Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis显示文摘	Patel V Senderowicz AM Pinto D Jr	1998	J Clin Invest1998，102，9：	1
10	Flavopiridol:the first cyclin dependent kinase inhibitor in human clinical trials显示文摘		1999	Invest New Drugs1999，17，3：	1
11	Flavopiridol: the first cyclin-dependent ki- nase inhibitor in human clinical trials 显示文摘	SENDEROWICZ AM	1999	Invest New Drugs1999，17，3：	1
12	The Cell Cycle as a Target for Cancer Therapy:Basic and Clinical Findings with the Small Molecule Inhibitors Flavopiridol and UCN-01显示文摘		2002	Oncologist2002，7，3：	1
13	Erlotinib/gemcitabine for first-line treament of locally advanced or metastatic adenocarcinoma of the pancreas显示文摘	Senderowicz AM Johnson JR Sridhara R	2007	Oncology2007，21，：	1
14	Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials显示文摘	Senderowicz AM	1999	Invest New Drugs1999，17，3：	1
15	Precl-inical and clinical develop- ment of cyclin-dep-endent kinase modulators 显示文摘	Senderowicz AM Sausville EA	2000	J Natl Cancer Inst2000，92，5：	1
16	The Cell Cycle, as a Target for Cancer Therapy: Basic and Clinical Findings with the Small Molecule Inhibitors Flavopiridol and UCN-01显示文摘	SENDEROWICZ AM	2002	Oncologist2002，7，3：	1
17	Targeting cell cycle and apoptosis for the treatment of human malignancies显示文摘	Senderowicz AM	2004	Curr Opin Cell Biol2004，16，：	1
18	Novel direct and indirect cyclin- dependent kinase modulators for the prevention and treatment of human neoplasms显示文摘	Senderowicz AM	2003	Cancer Chemother Phar- macol2003，，：	1
19	RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells显示文摘	Mukhopadhyay UK Senderowicz AM Ferbeyre G	2005	Cancer Res2005，65，：	1
20	Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis 显示文摘	Senderowicz AM Pinto DJ	1998	J Clin Investig1998，102，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示